Neurofibromatosis type 1 with concurrent multiple endocrine disorders: Adenomatous goiter, primary hyperparathyroidism, and acromegaly

3Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.

Abstract

We encountered a 70-year-old Japanese woman with neurofibromatosis type 1 (NF1) who had a history of pheochromocytoma and concurrently developed adenomatous goiter, primary hyperparathyroidism, and acromegaly. The patient had a somatotroph adenoma of the adenohypophysis that predisposed her to multinodular goiter. Three parathyroid tumors were detected by cervical ultrasonography and cervicothoracic computed tomography. Genetic analyses did not reveal genetic alterations (e.g. loss-of-function mutation) in the causative genes of endocrine tumors, including MEN1, RET, VHL, CDKN1B, and CDKN2C. The NF1 gene could not be analyzed genetically due to the patient’s refusal. The pathophysiologic mechanisms of endocrinopathy concurrence in NF1 remain to be elucidated.

Cite

CITATION STYLE

APA

Yasuda, S., Inoue, I., & Shimada, A. (2021). Neurofibromatosis type 1 with concurrent multiple endocrine disorders: Adenomatous goiter, primary hyperparathyroidism, and acromegaly. Internal Medicine, 60(15), 2451–2459. https://doi.org/10.2169/internalmedicine.4981-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free